Event Timing: April 3rd, 2024 from 3:00 - 4:30
Location: Virtual - Via Zoom Link sent by Paul Huiras the morning of the event 04/03/24
Non-ACPE CE is provided via MSHP Heartland through the MN BOP
Presented by:
Riley Larson-Adams, PharmD – PGY1 – Essentia Health – St. Joseph’s Medical Center
Kristen Olson, PharmD – PGY1 – U of M – Paynesville CentraCare
Cara Helgeson, PharmD – PGY1 – U of M – St. Cloud / CentraCare
Trista Betz, PharmD – PGY1 – U of M – Paynesville CentraCare
Jaden Gossen, PharmD - PGY1 - U of M - St. Cloud VA Health Care System
Alexis Duevel, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Emily Hayes, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Paige Putz, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Objectives:
• Identify patients with gout that may benefit from the addition of an SGLT2 inhibitor
• Evaluate the use of IVIG as adjunctive therapy in a patient with Streptococcal Toxic Shock Syndrome
• Compare CGRP antagonist treatments in migraine prevention.
• Determine when or if 10 days of Oseltamivir for hospitalized patients is appropriate
• Recognize safe and appropriate prescribing of buprenorphine for chronic pain management
• Evaluate buprenorphine long-acting injections dosing options and efficacy to make informed treatment decisions
• Compare and contrast symptom-triggered and weight-based phenobarbital dosing strategies for acute alcohol withdrawal in the emergency department
• Outline ISMP best practice recommendations for tranexamic acid and identify mechanisms to prevent medication errors
Print Page